The Biotech Growth Trust PLC (BIOG) — Cash Flow-to-Debt Ratio
The Biotech Growth Trust PLC (BIOG) has a Cash Flow-to-Debt Ratio of -0.08x as of September 2025, meaning its operating cash flow of GBX-2.52 Million could theoretically repay 0% of its total liabilities (GBX32.10 Million) in one year. Explore BIOG strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
The Biotech Growth Trust PLC Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for The Biotech Growth Trust PLC across 14 annual periods. Also explore The Biotech Growth Trust PLC asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for The Biotech Growth Trust PLC (2012–2025)
Year-by-year debt coverage analysis for The Biotech Growth Trust PLC. For market capitalisation and broader financial context, see how much is The Biotech Growth Trust PLC worth.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.94x | GBX-5.09 Million | GBX5.42 Million | ▼ -1008.4% |
| 2024 | -0.08x | GBX-4.24 Million | GBX50.11 Million | ▲ +56.6% |
| 2023 | -0.19x | GBX-5.89 Million | GBX30.22 Million | ▲ +46.6% |
| 2022 | -0.37x | GBX-12.14 Million | GBX33.24 Million | ▼ -209.4% |
| 2021 | -0.12x | GBX-5.67 Million | GBX48.06 Million | ▼ -11.7% |
| 2020 | -0.11x | GBX-3.77 Million | GBX35.62 Million | ▲ +46.3% |
| 2019 | -0.20x | GBX-4.40 Million | GBX22.36 Million | ▼ -37.5% |
| 2018 | -0.14x | GBX-4.11 Million | GBX28.68 Million | ▲ +64.6% |
| 2017 | -0.40x | GBX-5.29 Million | GBX13.08 Million | ▼ -218.5% |
| 2016 | -0.13x | GBX-5.91 Million | GBX46.58 Million | ▼ -1060.3% |
| 2015 | 0.01x | GBX703.00K | GBX53.23 Million | ▲ +101.0% |
| 2014 | -1.30x | GBX-52.25 Million | GBX40.19 Million | ▼ -2603.2% |
| 2013 | 0.05x | GBX1.15 Million | GBX22.22 Million | ▲ +167.9% |
| 2012 | -0.08x | GBX-439.00K | GBX5.74 Million | — |